Clinical Research Directory
Browse clinical research sites, groups, and studies.
Baerveldt Versus Paul Study
Sponsor: University of Sydney
Summary
The Baerveldt Versus Paul (BvP) Study is a Registry-based Randomised Controlled Trial, Comparing the Baerveldt Glaucoma Implant (BGI) and the Paul Glaucoma Implant (PGI). Participants will Include patients requiring aqueous shunt surgery for control of intraocular pressure and glaucoma. The objective of this study is to compare the long-term safety and effectiveness of placement of a BGI and PGI for patients who are undergoing aqueous shunt implant surgery. Patients who qualify for the study are randomized to receive either a BGI or PGI aqueous shunt.
Official title: The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2026-10-12
Completion Date
2033-04
Last Updated
2026-08-03
Healthy Volunteers
Yes
Conditions
Interventions
Baerveldt Glaucoma Implant
Surgical insertion of an aqueous shunt for control of intraocular pressure and/or glaucoma
Paul Glaucoma Implant
Surgical insertion of an aqueous shunt for control of intraocular pressure and/or glaucoma
Locations (4)
Sydney Eye Hospital
Sydney, New South Wales, Australia
Westmead Hospital
Sydney, New South Wales, Australia
Liverpool Hospital
Sydney, New South Wales, Australia
Royal Victorian Eye and Ear Hospital
Melbourne, Victoria, Australia